A

Adaptive Biotechnologies Corp
D

ADPT

4.69500
USD
0.33
(7.44%)
مغلق
حجم التداول
103,498
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
692,885,687
أصول ذات صلة
    I
    ILMN
    -7.180
    (-5.05%)
    135.110 USD
    M
    MTD
    -57.09
    (-4.61%)
    1,180.92 USD
    M
    MYGN
    -0.460
    (-2.93%)
    15.230 USD
    N
    NVTA
    0
    (0%)
    0.000000 USD
    O
    OPK
    0.01500
    (0.92%)
    1.64500 USD
    P
    PKI
    1.920
    (1.57%)
    124.190 USD
    P
    PODD
    -0.83
    (-0.32%)
    260.18 USD
    TMO
    TMO
    -19.95
    (-3.74%)
    513.04 USD
    T
    TNDM
    -1.240
    (-4.34%)
    27.330 USD
    V
    VEEV
    -16.200
    (-7.06%)
    213.260 USD
    المزيد
الأخبار

العنوان: Adaptive Biotechnologies Corp

القطاع: Healthcare
الصناعة: Biotechnology
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product,clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is alsoavailable as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).